Drugs

Medivation Announces Fourth Quarter and Year-End 2015 Financial Results Teleconference on February 25, 2016

SAN FRANCISCO, CA: ...

Flamel Technologies Acquires FSC Pediatrics

LYON, FRANCE: Diversifies Product Portfolio and Brings Established Commercial Infrastructure; Revised Full Year 2016 Revenue Guidance of $110 to $130 Million; Conference Call Today at 5:30 pm ET to Discuss the Tran ...

Innoviva Reports Fourth Quarter and Full Year 2015 Financial Results

SOUTH SAN FRANCISCO, CA: Company Reports Its First Quarterly Net Income, Generating $4.3 Million in Q4 2015; Repurchased Approximately $37 Million of Stock Through the End of January 2016; Company to Host Conference Call and ...

West to Present at LEERINK Conference

EXTON, PA: ...

Braeburn Pharmaceuticals and Knight Therapeutics Announce Canadian Sublicense Agreement for PROBUPHINE(R)

PRINCETON, NEW JERSEY and MONTREAL, QUEBEC: ...

Horizon Pharma plc to Host Fourth Quarter 2015 Conference Call and Webcast on February 29, 2016

DUBLIN, IRELAND: ...

MSI Methylation Sciences Inc. (MSI) Announces Results From the Horizon Phase 2 Trial for its Novel Treatment, MSI-195, for Major Depressive Disorder (MDD)

VANCOUVER, BRITISH COLUMBIA: ...

INTEGA Skin Looks GUD to Knight

MONTREAL, QUEBEC: ...

Cleveland BioLabs Attains Orphan Drug Status From the EMA for Entolimod as a Radiation Countermeasure

BUFFALO, NY: ...

Zucara Therapeutics Inc. Developing Drug to Prevent Hypoglycemic Episodes for People With Diabetes

TORONTO, ONTARIO and VANCOUVER, BRITISH COLUMBIA: ...